Validation of Arabic patient-reported outcome measures for head and neck cancer during radiotherapy
Arabic Patient-reported Outcome Measures During Radiotherapy for Head and Neck Cancer: a Validation Study
This study is testing new surveys to see if they accurately capture the experiences of Arabic-speaking patients with head and neck cancer during their radiotherapy treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 125 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | King Saud University Academic / other |
| Locations | 1 site (Riyadh) |
| Trial ID | NCT06662929 on ClinicalTrials.gov |
What this trial studies
This study aims to validate patient-reported outcome measures (PROMs) specifically for Arabic-speaking patients undergoing radiotherapy for head and neck cancer. By assessing the concerns and experiences of these patients through surveys administered before, during, and after treatment, the study seeks to ensure that the PROM tools are culturally relevant and effective. The findings will help clinicians better understand the specific needs and outcomes of Arabic patients, ultimately improving care and treatment strategies.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who are receiving or have received radiotherapy for head and neck cancer at King Saud University Medical City.
Not a fit: Patients under 18 years old or those with debilitating diseases that impair their ability to participate will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the quality of care for Arabic-speaking patients with head and neck cancer by providing validated tools to assess their treatment experiences and outcomes.
How similar studies have performed: While the validation of PROMs in Arabic-speaking populations is less common, similar studies in other cultural contexts have shown success in improving patient care.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults aged 18 or above and who is planned for receiving and who is currently receiving and who had already received radiotherapy for the HNC at King Saud University Medical City. Exclusion Criteria: * Individuals who are less than 18 years, presence of debilitating disease (e.g. heart failure) or who lack the capacity to read, understand and sign the informed consent and those.
Where this trial is running
Riyadh
- King Saud University Medical City — Riyadh, Saudi Arabia (Recruiting)
Study contacts
- Study coordinator: Abdullah M Alsoghier, PhD
- Email: aalsoghier@ksu.edu.sa
- Phone: +966114677423
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.